Potential role of mitogenic and proteolytic factors of the peritoneal fluid in the pathophysiology of endometrisis;Role potentiel de facteurs mitogeniques et proteolytiques du liquide peritoneal dans la physiopathologie de l'endometriose

References en Gynecologie Obstetrique

Volumn 5, Issue 2, 1997, Pages 205-211

  Lemay, A ^a   Koutsilieris, M ^a   Akoum, A ^a   Maheux, R ^a  

^a NONE

Author keywords

Endometriosis; Endometrium; Growth factor; Peritoneal fluid; Protease

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; CYTOKINE RELEASE; ENDOMETRIOSIS; GROWTH REGULATION; HORMONAL REGULATION; MITOGENESIS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION;

EID: 0031400077     PISSN: 12448168     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Giudice L.C. 1994. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 61,1-17.
2. Chang S.Y., Ho Y.S. 1997. Immunohistochemical analysis of insulin-like growth factor-I, insulin like growth factor-I receptor and insulin-like growth factor-II in endometriotic tissue and endometrium. Acta Obstet Gvnecol Scand 76; 112-117.
3. Sbracia M., Zupi E., Alo P., Manna C., Marconi D., Scarpellini F., Grasso J.A., Ditondo U., Romanini C. 1997. Differential expression of IGF-I and IGF-II in eutopic and ectopic endometria of women with endometriosis and in women without endometriosis. Am J Reprod Med 37;326-329.
4. Ferriani R.A., Charnock-Jones D.S., Prentice A., Thomas E.J., Smith S.K. 1993. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod 8,11-16.
5. Shifren J.L., Tseng J.F., Zatoudek C.J., Ryan I.P., Meng G., Ferrara N., Jaffe R.B., Taylor R.N. 1996. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81,3112-3118.
6. McLaren J., Prentice A., Charnock-Jones D.S., Millican S.A., Müller K.H., Sharkey A.M., Smith S.K. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis dan is regulated by ovarian steroids. Am Society Clin invest 98;482-489.
7. Simms J.S., Chigini N., Williams R.S., Rossi A.M., Dunn WA. 1991. Identification of epidermal growth factor, transforming growht factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats. Obstet Gynecol 78,850-857.
8. Chegini N., Gold I.L., Williams R.S. 1994. Localization of transforming growth factor beta isoform TFG-β1, TGF-β2, and TGF, b3 in surgically induced endometriosis in the rat. Obstet Gynecol 83,455-461.
9. Tan X.M., Zhao Y., Rossi M.J., Abu-Rustum R.S., Ksander G.A., Chegini N. 1994. Expression of transforming growht factor-β (TGFβ) isoforms and TGFβ type n receptor messenger ribonucleic acid and protein, and the effect of TGFβs on endometrial stromal cell growth and protein degradation in vitro. Endocrinol 135,450-459.
10. Arici A., MacDonald P.C., Casey M.L. 1996. Modulation of the Levels of transforming growth factor β messenger ribonucleic acids in human endometrial stromal cells. Biol Reprod 54,463-469.
11. Ramey J.W., Archer D.F. 1993. Peritoneal fluid: its relevance to the development of endometriosis. Fertil Steril 60,1-14.
12. Oosterlynck D.J., Meuleman C., Waer M., Koninckx P.R. 1994. Transforming growth factor-b activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 83, 287-292.
13. Weinberg J.B., Haney A.F., Xu F.J., Ramakrishnan S. 1991. Peritoneal fluid and plasma levels of human macrophage colony-stimulating factor in relation to peritoneal flud macrophage content. Blood 78,513-516.
14. Halme J., Kauma W.S., Estes J., Haskill S. 1988. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 66, 1044-1049.
15. Surrey E.S., Halme J. 1990. Effect of peritoneal fluid from endometriosis patients on endometrial stromal cell proliferation in vitro. Obstet Gynecol 76,792-797.
16. Meresman G.F., Barnanao R.I., Tanenbaum A., Singla J.J., Neuspilier N.R., Rumi L.S. 1997. Effect of peritoneal-fluid from patients with mild and severe endometriosis on endometrial stromal cell proliferation. Arch Gvnecol Obstet 259:109-115.
17. Giudice L.C., Dsupin B.A., Gargosky S.E., Rosenfeld R.G., Irwin J.C. 1994. The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis. J Clin Endocrinol Metab 79,1284-1293.
18. Koutsilieris M., Allaire-Michaud L., Fortier M., Lemay A. 1991. Mitogen(s) for endemetrial-like cells can be detected in human peritoneal flud. Fertil Steril 56,888-893.
19. Koutsilieris M., Niklinski W., Frenette G., Lemay A. 1993. Heparin-sepharose binding growth factors in peritoneal fluid of women wan endometriosis. Fertil Steril 59;93-97.
20. Koutsilieris M., Akoum A., Lazure C., Frenette G., Lemay A. and Le Groupe d'investigation en gynécologie 1995. N-terminal truncated forms of insulin-like growth factor binding protein-3 inthe peritoneal fluid of women without laparoscopic evidence of endometriosis. Fertil Steril 63;314-321.
21. Binoux M., Hossenlopp P., Lassarre C., Segovia B. 1991. Degradation of IGF binding protein-3 by proteases: physiological implications. In: Proceedings of the 2nd International Symposium on Insulin-like growth factor/Somatomedins. E.M. Spencer ed. Elsevier Science Publishing Co., Inc., 329-336.
22. Lamson G., Giudice L.C., Cohen P., Liu F., Gargosky S., Muller H.L., Oh Y., Wilson K.F., Hintz R.L., Rosenfeld R.G. 1993. Proteolysis of IGFPB-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regulation 3:91-95.
23. Oh Y., Muller H.L., Lamson G., Rosenfeld R.G. 1993. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268, 14964-14971.
24. Koutsilieris M., Lavergne E., Lemay A. 1997. Association of protease activity against IGFBP-3 with peritoneal fluid mitogens: possible implications for the ectopic growth of endometrial cells in women with endometriosis. Anticancer Res 17:1239-1244.
25. Giudice L.C., Farrell E.M., Pham H., Lamson G., Rosenfeld R.G. 1990. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metabl 71,806-816.
26. Cohen P., Graves H.C.P., Peehl D.M., Kamarei M., Giudice L.C., Rosenfeld R.G. 1992. Prostate specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in sseminal plasma. J Clin Endocrinol Metab 75:1046-1053.
27. Nonoshita L.D., Wathen N.C., Dsupin B.A., Chard T., Giudice L.C. 1994. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions. J Clin Endocrinol Metab 79,1249-1255.
28. Bang P., Brismar K., Rosenfeld R.G. 1994. Increase proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29 kilodalton (kDa) glycosylated IGFBP-3 fragment contained in ten approximately 130- to 150 kDa ternary complex. J Clin Endocrinol Metab 78, 1119-1127.
29. Frost V.J., Helle S.I., Lonning P.E., van der Strappen J.W.J., Holly J.M.P. 1996. Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer. J Clin Endocrinol Metab 81 :2216-2221.
30. Muller H.L., Oh Y., Gargosky S.E., Lehrnbecher T., Hintz R.L., Rosenfeld R.G. 1993. Concentrations of insulin-like growth factor (IGF)- binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 77, 1113-1119.
31. Matsumoto T., Gargosky S.E., Iwasaki K., Rosenfeld R.G. 1996. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 81, 150-155.
32. Rodgers W.H., Osteen K.G., Matrisian L.M., Navre M., Giudice L.C., Gorstein F. 1993. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. J Obstet Gynecol 168; 253-260.
33. Head J.R., MacDonald P.C., Casey M.L. 1993. Cellular localization of membrane metalloendopeptidase (enkephalinae) in human endometrium during the ovarian cycle J Clin Endocrinol Metab 76:769-776.
34. Fernandez-Shaw S., Marshall J.M., Hicks B., Barlow D.H., Starkey P.M. (1995). Plasminogen activators in ectopic and uterine endometrium. Fertil Steril 63 :45-51.
35. Osteen K.G., Rodgers W.H., Gaire M., Hargrove J.T., Gorstein F., Matrisian L.M. 1994. Stromal epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 91:10129-10133.
36. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M., Osteen K.G. 1995. Transforming growth factor b mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl. Acad Sc. USA 92:7362-7366.
37. Casey M.L., Mac Donald P.C. 1996. Transforming growth factor-b inhibits protesterone-induced enkephalinase expression in human endometrial stromal cells. J Clin Endocrinol Metab 81 :4022-4027.
38. Clements J., Mukhtar A. 1994. Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 78:1536-1539.
39. Bergqvist A., Ferno M., Mattson S. 1996. A comparison of cathepsin D levels in endometriotic tissue and in uterine endometrium. Fertil Steril 65:1130-1134.
40. Rawdanowicz T.J., Hampton A-L., Nagase H., Woolley D.W., Salamonesen L.A. 1994. Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatine-B, and stromelysin-1 and their differential regulation by interleukin-1α and tumor necrosis factor-α. J Clin Endocriol Metab 79:530-536.
41. Casslen B., Nordengren J., Gustavsson B., Nilbert M., Lund L.R. 1995. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. J Clin Endocrinol Metab 80:2776-2784.
42. Martelli M., Capana A., Bischof P. 1993. Sécrétion des matrixines par l'endomètre humain. Gynecol Obstet 1:200-213.
43. Higuchi T., Kanzaki R, Nakayama H., Fujomoto M., Hatayama H., Kojima K., Iwai M., Mori T., Fujita J. 1995. Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells Endocrinology 136:4973-4981.
44. Sharpe-Timms K.L., Penney L.L., Zimmer R.L., Wright J.A., Zhang Y., Surewicz K. 1995. Partial purification and amino acid sequence analysis of endometriosis protein-II (Endo-II) reveales homology with tissue inhibitor of metallopreoteinase-I (TIMP-1) J Clin Endocrinol Metab 80;3784-3787.
45. Astedt B., Nordenskjold F. 1984. Plasminogen activators in endometriosis Acta Obstet Gynecol Scand Suppl 123:23-24.
46. Koutsilieris M., Frenette G., Lazure C., Lehoux J-G, Govindan MV, Plychornakos C. 1993. Urokinase-type plasminogen activator: A paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 13:481-486.